About Event
IP & Patent Strategy for Advanced Therapies Summit – What’s It About?
Taking place for the first time in 2025, the IP & Patent Strategy for Advanced Therapies Summit is the only event dedicated exclusively to patent strategy for cell, gene, and next-generation therapies. As more complex treatments enter the pipeline and legal frameworks rapidly evolve, this summit arrives at a critical moment for IP leaders. With fresh perspectives on AI-powered searches, early-stage patentability, and creative transactional strategies, you’ll gain practical insights impossible to find elsewhere. Don’t miss your chance to shape your approach alongside pioneers setting the standard for protecting innovation in advanced therapies.
Master early-stage patentability and freedom to operate strategies tailored to advanced therapies.
Learn how strategic IP decisions can drive funding, investor confidence, and market access.
Align global filing strategies with commercial goals to optimize cost, risk, and market reach.
Balance patents, trade secrets, and transactional models to secure long-term exclusivity.
Discover how to structure licensing, acquisitions, and partnerships to maximize IP value.
Who Will You Meet?
This event will bring together in-house IP experts from biopharma companies primarily working in the advanced therapy space.
What Your Peers Have to Say
“The opportunity for undirected communication with peers within the panel discussions and informally at breaks led to the sharing of experiences and insights that were immediately actionable and facilitated networking. ”
In-House Impact: Biopharma Past Attendee
“This is my favorite conference annually. The focus on attorneys as business partners and hearing individual and collective experiences of business-focused, revenue-driving attorneys is invaluable. ”
In-House Impact: Biopharma Past Attendee
